miRNA在慢性鼻窦炎伴鼻息肉中的作用及其研究进展
作者:
基金项目:

四川省科技厅重点研发计划(重大科技专项)(2022YFS0067);电子科技大学中央高校基金(ZYGX2019J110)。


Research progress on the role of miRNA in chronic rhinosinusitis with nasal polyps
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    慢性鼻窦炎伴鼻息肉(CRSwNP)是耳鼻咽喉科的常见病,其发病机制至今尚不完全清楚, CRSwNP以鼻腔和鼻窦黏膜的高度异质性慢性炎症为特征。炎性改变已被广泛认为是CRSwNP的致病机制。但炎性调控网络复杂,目前尚不清楚哪些关键的上游因子可能参与了CRSwNP的炎性状态。近年研究发现microRNA(miRNA)在CRSwNP的发病过程中起着重要的调控作用,具体可能通过表观遗传等方式参与了这一过程。本文围绕miRNA在CRSwNP中的可能作用,特别聚焦其在炎性环境改变中的潜在作用,包括其表达模式、功能以及潜在的临床应用,归纳了miRNA有关CRSwNP炎症机制及非炎症机制的研究进展,为后续研究提供理论基础。

    Abstract:

    Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common disease in otorhinolaryngology. The pathogenesis of CRSwNP is still fully unclear. CRSwNP is characterized by highly heterogeneous chronic inflammation of nasal cavity and sinus mucosa. Inflammatory changes have been widely regarded as the pathogenesis of CRSwNP. However, it is complex for the inflammatory regulatory network. Of which contain in their upstream factors, and it is not still understand to be involved in the inflammatory state of CRSwNP. Recent studies have found that microRNA (miRNA) plays an important role in regulating the pathogenesis of CRSwNP. It may be involved in the process of the disease by means of epigenetic inheritance. This paper focuses on the possible role of miRNA in CRSwNP, especially its potential role in inflammatory environment changes, including its expression pattern, function and potential clinical application. We summarized the research progress of miRNA on inflammatory and non-inflammatory mechanisms of CRSwNP, which provided a theoretical basis for further research.

    网友评论
    网友评论
    分享到微博
    发 布
    参考文献
    [1] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020,58(Suppl S29):1-464.
    [2] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.中国慢性鼻窦炎诊断和治疗指南(2018)[J].中华耳鼻咽喉头颈外科杂志, 2019, 54(2):81-100.
    [3] 王宇婷,姜辉,王嘉玺. 变应性鼻炎中lncRNA-miRNA-mRNA网络构建与相关程序性细胞死亡基因的分析[J]. 中国耳鼻咽喉颅底外科杂志,2023,29(3):54-63.
    [4] Kim B, Rothenberg ME, Sun X, et al. Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases [J]. J Allergy Clin Immunol, 42024,153(4):879-893.
    [5] Zhu Z, Lan J, Wei R, et al. Microbiome and Th cytokines association in chronic rhinosinusitis with or without nasal polyp[J]. Laryngoscope Investig Otolaryngol, 2023,8(2):335-345.
    [6] Su H, Zhao Y. Eupatilin alleviates inflammation and epithelial-to-mesenchymal transition in chronic rhinosinusitis with nasal polyps by upregulating TFF1 and inhibiting the Wnt/β-catenin signaling pathway [J]. Histol Histopathol, 2024,39(3):357-365.
    [7] Chen J, Chen S, Gong G, et al. Inhibition of IL-4/STAT6/IRF4 signaling reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polyps[J]. Int Immunopharmacol, 2023,121:110554.
    [8] Hu J, Liu Y, Pan Z, et al. Eupatilin ameliorates hepatic fibrosis and hepatic stellate cell activation by suppressing β-catenin/PAI-1 pathway[J]. Int J Mol Sci, 2023,24(6):5933.
    [9] Bachert C, Laidlaw TM, Cho SH, et al. Effect of dupilumab on type 2 biomarkers in chronic rhinosinusitis with nasal polyps: SINUS-52 study results[J]. Ann Otol Rhinol Laryngol, 2023,132(12):1649-1661.
    [10] 李游,林慧敏,张筱娴,等.度普利尤单抗治疗慢性鼻窦炎伴鼻息肉的疗效分析[J].中国耳鼻咽喉颅底外科杂志, 2022,28(2):61-66.
    [11] Ramírez-Jiménez F, Pavón-Romero GF, Velásquez-Rodríguez JM, et al. Biologic therapies for asthma and allergic disease: Past, present, and future[J]. Pharmaceuticals (Basel),2023,16(2):270.
    [12] Cui Y, Qi Y, Ding L, et al. miRNA dosage control in development and human disease [J]. Trends Cell Biol, 2024,34(1):31-47.
    [13] Mishra S, Yadav T, Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics[J]. Crit Rev Oncol Hematol, 2016,98:12-23.
    [14] Peixoto P, Cartron PF, Serandour AA, et al. From 1957 to nowadays: A brief history of epigenetics[J]. Int J Mol Sci, 2020,21(20):7571.
    [15] Xia G, Bao L, Gao W, et al. Differentially expressed mirna in inflammatory mucosa of chronic rhinosinusitis[J]. J Nanosci Nanotechnol, 2015,15(3):2132-2139.
    [16] Luan G, Wang M, Yuan J, et al. MicroRNA-21-5p promotes mucosal type 2 inflammation via regulating GLP1R/IL-33 signaling in chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2022,150(6):1460-1475.
    [17] Liu T, Sun Y, Bai W. The role of epigenetics in the chronic sinusitis with nasal polyp[J]. Curr Allergy Asthma Rep, 2020,21(1):1.
    [18] Wu Y, Sun K, Tu Y, et al. miR-200a-3p regulates epithelial-mesenchymal transition and inflammation in chronic rhinosinusitis with nasal polyps by targeting ZEB1 via ERK/p38 pathway [J]. Int Forum Allergy Rhinol, 2024,14(1):41-56.
    [19] Basu P, Maier C, Averitt DL, et al. NLR family pyrin domain containing 3 (NLRP3) inflammasomes and peripheral neuropathic pain - Emphasis on microRNAs (miRNAs) as important regulators[J]. Eur J Pharmacol, 2023,955:175901.
    [20] Ibáñez-Cabellos JS, Pallardó FV, García-Giménez JL, et al. Oxidative stress and epigenetics: mirna involvement in rare autoimmune diseases[J]. Antioxidants (Basel), 2023,12(4):800.
    [21] Mimmi S, Lombardo N, Maisano D, et al. Spotlight on a short-time treatment with the IL-4/IL-13 receptor blocker in patients with CRSwNP: microRNAs modulations and preliminary clinical evidence[J]. Genes (Basel), 2022,13(12):2366.
    [22] Luan G, Wang M, Yuan J, et al. MicroRNA-21-5p promotes mucosal type 2 inflammation via regulating GLP1R/IL-33 signaling in chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2022,150(6):1460-1475.
    [23] 黄伟强,黄子真,赖晓萍,等. ACE2在慢性鼻窦炎伴鼻息肉中的表达及调控分析[J]. 中华耳鼻咽喉头颈外科杂志,2022,57(6):692-698.
    [24] Li X, Li C, Zhu G, et al. TGF-β1 induces epithelial-mesenchymal transition of chronic sinusitis with nasal polyps through microrna-21[J]. Int Arch Allergy Immunol, 2019,179(4):304-319.
    [25] Silveira DA, Gupta S, da Cunha Jaeger M, et al. A logical model of Ewing sarcoma cell epithelial-to-mesenchymal transition supports the existence of hybrid cellular phenotypes[J]. FEBS Lett, 2023,597(19):2446-2460.
    [26] Chen L, Heikkinen L, Wang C, et al. Trends in the development of miRNA bioinformatics tools[J]. Brief Bioinform, 2019,20(5):1836-1852.
    [27] Wang Y, Li H, Liu X, et al. Three alternative splicing variants of Loquacious play different roles in miRNA- and siRNA-mediated RNAi pathways in Locusta migratoria[J]. RNA Biol, 2023,20(1):323-333.
    [28] Zhang YN, Cao PP, Zhang XH, et al. Expression of microRNA machinery proteins in different types of chronic rhinosinusitis[J]. Laryngoscope, 2012,122(12):2621-2627.
    [29] Chen JC, Xing QL, Yang HW, et al. Construction and analysis of a ceRNA network and patterns of immune infiltration in chronic rhinosinusitis with nasal polyps: based on data mining and experimental verification[J]. Sci Rep, 2022,12(1):9735.
    [30] Li K, Liu FF. Analysis of competing endogenous RNA (ceRNA) crosstalk in eosinophilic chronic rhinosinusitis with nasal polyps[J]. Int Forum Allergy Rhinol, 2022,12(12):1468-1479.
    [31] Zhou X, Zhen X, Liu Y, et al. Identification of key modules, hub genes, and noncoding rnas in chronic rhinosinusitis with nasal polyps by weighted gene coexpression network analysis[J]. Biomed Res Int, 2020,2020:6140728.
    [32] Brar T, Marks L, Lal D. Insights into the epigenetics of chronic rhinosinusitis with and without nasal polyps: a systematic review[J]. Front Allergy, 2023,4:1165271.
    [33] Park JH, Shin JM, Yang HW, et al. DNMTs are involved in TGF-β1-induced epithelial-mesenchymal transitions in airway epithelial cells[J]. Int J Mol Sci, 2022,23(6):3003.
    [34] Liu T, Sun Y, Bai W. The Role of epigenetics in the chronic sinusitis with nasal polyp[J]. Curr Allergy Asthma Rep, 2020,21(1):1.
    [35] Bachert C, Zhang L, Gevaert P. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis[J]. J Allergy Clin Immunol, 2015,136(6):1431-1440.
    [36] Paparo L, Nocerino R, Bruno C, et al. Randomized controlled trial on the influence of dietary intervention on epigenetic mechanisms in children with cow’s milk allergy: the EPICMA study [J]. Sci Rep,2019,9(1):2828.
    引证文献
引用本文

石明佳,古庆家. miRNA在慢性鼻窦炎伴鼻息肉中的作用及其研究进展[J].中国耳鼻咽喉颅底外科杂志,2024,30(5):37-41

复制
分享
文章指标
  • 点击次数:45
  • 下载次数: 91
历史
  • 收稿日期:2023-09-21
  • 在线发布日期: 2024-11-05
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭